Stock listing

Cormedix Inc.

Selected listing: 19KA · SWB · EUR · DE

Cormedix Inc. (Stuttgart:19KA), Health Technology. Latest release Sep 1, 2026: CorMedix Therapeutics to Participate in the Wells Fargo Healthcare Conference.

19KA:SWBEURDEUpdated September 25, 2026

Ticker: Stuttgart:19KA
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Stuttgart
Currency: EUR

About Cormedix Inc.

The company focuses on developing and commercializing innovative products to improve patient outcomes in the healthcare sector. Cormedix is committed to addressing unmet medical needs through its research and development efforts.

Latest news from Cormedix Inc.

CorMedix Therapeutics to Participate in the Wells Fargo Healthcare Conference

September 1, 2026

Cormedix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

August 13, 2026

CorMedix Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 13, 2026

July 29, 2026

CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB)

July 14, 2026

U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation

June 7, 2026

All Cormedix Inc. news →

Events

Replays

CorMedix Inc. (CRMD) Q2 2026 Earnings Call
Thu, Aug 13, 2026 · 08:30 AM ET
Watch
CorMedix Inc. (CRMD) Q1 2026 Earnings Call
Thu, May 14, 2026 · 08:30 AM ET
Watch
CorMedix Inc. (CRMD) Q4 2025 Earnings Call
Thu, Mar 05, 2026 · 08:30 AM ET
Watch

Research Cormedix Inc.

Cormedix Inc. company profile

View the public company page for Cormedix Inc. on 6ix.

Cormedix Inc. news

Read company news and market updates connected to Cormedix Inc..

Cormedix Inc. investor events

Find investor webinars, events, and replay context for Cormedix Inc..